coronary heart disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? Subjects with stable coronary heart disease who have objective evidence of ischemia (coronary stenosis =50% confirmed by coronary angiography or coronary CTA) and stable symptoms (angina grading CCSI~II), complete revascularization, and have received standard drug therapy for coronary heart disease for more than 4 weeks; ?30-75 years old; ? No EECP treatment in the past 3 months.
Exclusion criteria
Exclusion criteria: ? Severe aortic valve insufficiency; ? Dissecting aneurysm; ? Significant pulmonary arterial hypertension; ? Various bleeding disorders or bleeding tendencies, or use of anticoagulants, INR>2.0; ? Various heart valve diseases or congenital heart diseases with heart failure; ? Active phlebitis and venous thrombosis cannot be treated together; ? There are infection foci in the limbs; ? Uncontrolled hyperglycemia (170/110mmHg); ? Uncontrolled arrhythmia; ? Acute myocarditis and pericarditis; ? Symptomatic aortic stenosis; ? Severe obstructive hypertrophic cardiomyopathy; ? Acute or severe heart failure; ? CCSIV angina pectoris ; ? Pregnancy; Other serious illnesses or limb movement disorders that affect movement; ? EF<50%; ? Unable to cooperate with treatment or research plan; ? Those who have participated in other research projects in the past three months;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| D/S ratio; | — |
Secondary
| Measure | Time frame |
|---|---|
| cardiac output;cardiac index;Stroke volume;Stroke volume index;Peripheral vascular resistance;Peripheral vascular resistance index; | — |
Countries
China
Contacts
The Eighth Affiliated Hospital of Sun Yat-sen University